|
DSTN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92530003051417E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.52819998269871E-09 |
| Normal-vs-Stage2 |
3.47850000026462E-07 |
| Normal-vs-Stage3 |
2.45030000001201E-06 |
| Normal-vs-Stage4 |
3.16700000002612E-06 |
| Stage1-vs-Stage2 |
6.792000E-01 |
| Stage1-vs-Stage3 |
9.111000E-01 |
| Stage1-vs-Stage4 |
4.007000E-01 |
| Stage2-vs-Stage3 |
6.750600E-01 |
| Stage2-vs-Stage4 |
7.613400E-01 |
| Stage3-vs-Stage4 |
4.404200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.32370003846916E-09 |
| Normal-vs-AfricanAmerican |
5.4904000235112E-09 |
| Normal-vs-Asian |
1.395590E-03 |
| Caucasian-vs-AfricanAmerican |
9.626000E-01 |
| Caucasian-vs-Asian |
8.658400E-01 |
| AfricanAmerican-vs-Asian |
8.187000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.879274513783E-12 |
| Normal-vs-Female |
3.574300E-04 |
| Male-vs-Female |
3.829300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.23089999976212E-07 |
| Normal-vs-Extreme_Weight |
2.07389999618002E-08 |
| Normal-vs-Obese |
1.21580000000954E-06 |
| Normal-vs-Extreme_Obese |
3.69939999966817E-07 |
| Normal_Weight-vs-Extreme_Weight |
9.223400E-01 |
| Normal_Weight-vs-Obese |
4.622800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.435400E-01 |
| Extreme_Weight-vs-Obese |
3.334800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.513200E-01 |
| Obese-vs-Extreme_Obese |
9.928400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.07879999999783E-05 |
| Normal-vs-Age(41-60Yrs) |
1.52859999991151E-07 |
| Normal-vs-Age(61-80Yrs) |
1.1411982470122E-11 |
| Normal-vs-Age(81-100Yrs) |
3.68630000002756E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.047000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.806400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.530800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.744100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.528600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.561600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.68940000772255E-09 |
| Normal-VS-Type2 PRCC |
2.08311146110418E-12 |
| Normal-VS-KIRP CIMP |
8.003200E-03 |
| Normal-VS-Unclassified PRCC |
6.17419999999758E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.792300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.151000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.344000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.339900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.761600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.819000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.86889989331974E-10 |
| Normal-vs-N1 |
1.36559999996955E-06 |
| Normal-vs-N2 |
4.417700E-03 |
| N0-vs-N1 |
2.392800E-01 |
| N0-vs-N2 |
7.368600E-01 |
| N1-vs-N2 |
8.114600E-01 |
|
|
